Results 181 to 190 of about 972,474 (267)

Associations of park visits, physical activity and health outcomes among churchgoing Latino adults in low-income urban communities. [PDF]

J Behav Med
Derose KP, Seelam R, Perez LG, Arredondo E, Han B, Castro G, Cohen DA.   +6 more
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Clinical validation of the Rapid Cough Questionnaire across diverse lung diseases. [PDF]

BMJ Open Respir Res
Koo HK, An TJ, Joo H, Rhee CK, Kim YH, Kim SK, Min KH, Kim DK, Shin JW, Yoon HK, Jang SH, Park YB, Kim JW, Moon JY, Korean Cough Study Group in the Korean Academy of Tuberculosis and Respiratory Disease (KATRD).   +14 more
europepmc   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

Pregnancy Outcomes in Women With Valvular Heart Disease: Insights From 30 Years of Single-Center Experience. [PDF]

J Korean Med Sci
Shin H, Park SJ, Oh SY, Son J, Lee J, Bang SH, Kim J, Kim EK, Lee SC, Park SW.   +9 more
europepmc   +1 more source

Astrocyte heterogeneity in brain metastases

Molecular Oncology, EarlyView.
Astrocytes emerge as pivotal regulators of metastatic colonization, survival, immune remodeling, and therapy response associated with an increasing heterogeneity that requires spatially and longitudinally resolved approaches to uncover regulatory programs and guide context‐specific therapies.
Carolina Hernández‐Oliver, Neibla Priego, Manuel Valiente   +2 more
wiley   +1 more source

Erratum to "Glycogen Phosphorylase Inhibitor Promotes Hair Growth via Protecting from Oxidative-Stress and Regulating Glycogen Breakdown in Human Hair follicles" [Biomol Ther 32(5), 640-646 (2024)]. [PDF]

Biomol Ther (Seoul)
Park B, Kim D, Zhao H, Kim S, Park BC, Lee S, Lee Y, Park HD, Lim D, Ryu S, Hwang JS.   +10 more
europepmc   +1 more source

From tumor‐centric to ecosystem‐based hypotheses in brain tumor research and care

Molecular Oncology, EarlyView.
Primary brain tumors, whether in adults or children, present a major challenge because of their dramatic prognosis and the ongoing lack of efficient therapeutic approaches. In recent years, a shift has occurred from tumor‐centric concepts to a more holistic view of these tumors as dynamic ecosystems.
Julie Gavard, Flavie Bénard, Eva Billat, Margaux Le Guyon, Victoria Maltret, Laura Merlet, Chloé Astrid Walter, Tony Avril, Eric Chevet   +8 more
wiley   +1 more source

Corrigendum to: Beneficial Effects of <i>Lacticaseibacillus paracasei</i> subsp. <i>paracasei</i> ABF21013 (ACE-01) on Skin Health by Regulating MMPs Production and EGFR Signal Pathway. [PDF]

J Microbiol Biotechnol
Lee S, Lee EJ, Ahn CW, Park HO, Lee C.
europepmc   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source